Literature DB >> 18303890

Powdered KOH in DMSO: an efficient base for asymmetric cyclization via memory of chirality at ambient temperature.

Takeo Kawabata1, Katsuhiko Moriyama, Shimpei Kawakami, Kazunori Tsubaki.   

Abstract

Enolate chemistry has been extensively used for stereoselective C-C bond formation, in which metal amide bases are frequently employed in strictly anhydrous solvents at low temperatures. However, we found that asymmetric intramolecular C-C bond formation via axially chiral enolate intermediates proceeded in up to 99% ee at 20 degrees C using powdered KOH in dry or wet DMSO as a base. The enantioselectivity was even higher than that of the corresponding reactions with potassium hexamethyldisilazide in DMF at -60 degrees C. The racemization barrier of the axially chiral enolate intermediate was estimated to be approximately 15.5 kcal/mol. On the basis of the barrier, the chiral enolate intermediate was supposed to undergo cyclization within approximately 10(-3) sec at 20 degrees C after it is generated to give the product in >or=99% ee. Thus, enolates generated with powdered KOH in DMSO were expected to be extremely reactive.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303890     DOI: 10.1021/ja077684w

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  3 in total

1.  Recent Progress on the Stereoselective Synthesis of Cyclic Quaternary alpha-Amino Acids.

Authors:  Carlos Cativiela; Mario Ordóñez
Journal:  Tetrahedron Asymmetry       Date:  2009-01-30

2.  Base-Mediated One-Pot Synthesis of Aliphatic Diazirines for Photoaffinity Labeling.

Authors:  Lei Wang; Zetryana Puteri Tachrim; Natsumi Kurokawa; Fumina Ohashi; Yasuko Sakihama; Yasuyuki Hashidoko; Makoto Hashimoto
Journal:  Molecules       Date:  2017-08-22       Impact factor: 4.411

3.  Base-catalyzed synthesis of aryl amides from aryl azides and aldehydes.

Authors:  Sheng Xie; Yang Zhang; Olof Ramström; Mingdi Yan
Journal:  Chem Sci       Date:  2015-10-22       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.